Clonotypic IgM transcripts are detectable among purified sIgM plus B cells from the peripheral blood of patients with multiple myeloma.

被引：0
|
作者：
Ye, M [1 ]
Taylor, BJ [1 ]
Keats, JK [1 ]
Belch, AR [1 ]
Pilarski, LM [1 ]
机构：
[1] Univ Alberta, Edmonton, AB T6G 2M7, Canada
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5214
引用
收藏
页码：371B / 372B
页数：2
相关论文
共 50 条
  • [1] Clonotypic B cells in the peripheral blood of patients with multiple myeloma
    Cremer, FW
    Goldschmidt, H
    Moos, M
    BLOOD, 2001, 97 (09) : 2913 - 2913
  • [2] NO DETECTABLE MALIGNANT-B CELLS IN THE PERIPHERAL-BLOOD OF PATIENTS WITH MULTIPLE-MYELOMA
    CLOFENT, G
    KLEIN, B
    COMMES, T
    GHANEM, N
    LEFRANC, MP
    BATAILLE, R
    BRITISH JOURNAL OF HAEMATOLOGY, 1989, 71 (03) : 357 - 361
  • [3] DNA methylation in peripheral blood and bone marrow mononuclear cells from patients with multiple myeloma.
    Borzecki, A
    Rolinski, J
    Borzecka, H
    Keith, G
    Sieklucka-Dziuba, M
    Kaluzny, Z
    Dmoszynska, A
    BLOOD, 2000, 96 (11) : 221B - 221B
  • [4] Statins use and peripheral blood progenitor cells mobilization in patients with multiple myeloma.
    Voutsadakis, Ioannis
    Stravodimou, Athina
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Peripheral blood myeloma cells as a prognostic factor for survival in patients with new, untreated multiple myeloma.
    Witzig, TE
    Gertz, MA
    Lust, JA
    Kyle, RA
    OFallon, WM
    Greipp, PR
    BLOOD, 1995, 86 (10) : 217 - 217
  • [6] Peripheral blood progenitor cell autografting in patients with multiple myeloma.
    Goldschmidt, H
    Hegenbart, U
    Egerer, G
    Fruhauf, S
    Voso, MT
    Hohaus, S
    Wannenmacher, M
    Haas, R
    BLOOD, 1997, 90 (10) : 1707 - 1707
  • [7] Bortezomib alters peripheral blood lymphocyte subsets in patients with multiple myeloma.
    Uy, GL
    Holt, MS
    Fisher, NM
    Devine, SM
    Tomasson, MH
    DiPersio, JF
    Vij, R
    BLOOD, 2005, 106 (11) : 672A - 672A
  • [8] Selecting peripheral blood progenitor cells (PBPC) by immunomagnetic bead separation in patients with multiple myeloma.
    Abonour, R
    Kunkel, LA
    Mills, B
    Srour, E
    Gharpure, V
    Hromas, R
    Robertson, M
    Broun, ER
    Rowley, SD
    Maziarz, R
    Oldham, FB
    Cometta, K
    BLOOD, 1996, 88 (10) : 2410 - 2410
  • [9] Effect of 24-hours culture with interleukin 2 on progenitor cells in peripheral blood stem cells from patients with multiple myeloma.
    Hájek, R
    Vorlicek, J
    Adler, J
    Vinklárková, J
    Janovská, E
    Korístek, Z
    Bourková, L
    Doubek, M
    Klabusay, M
    Mayer, J
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 776 - 776
  • [10] Differential expression of CD19 epitopes among B cells in patients with multiple myeloma.
    Taylor, BJ
    Belch, AR
    Zola, H
    Adamson, P
    Pilarski, LM
    BLOOD, 1999, 94 (10) : 121A - 121A
12345